Stay away from concomitant use of tucatinib with CYP3A substrates, where small focus adjustments may possibly produce severe or lifetime-threatening toxicities. If unavoidable, lower CYP3A substrate dose according to item labeling.Drowsiness or dizziness may previous for a longer period in older adults. Use caution to prevent slipping or accidental